Liver Disease Clinical Trials in San Diego, CA

46 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI	N/A	VA Office of Research and Development	<1 mi
DESTINY-PANTUMOUR04	—	AstraZeneca	<1 mi
Early Detection of Advanced Adenomas and Colorectal Cancer	—	City of Hope Medical Center	<1 mi
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors	Phase 1/2	DualityBio Inc.	<1 mi
Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients	—	University of California, San Diego	<1 mi
Implementing Food Referrals for Equity and Sustained Health	Phase 2	University of California, San Diego	<1 mi
The Myelin Disorders Biorepository Project	—	Children's Hospital of Philadelphia	<1 mi
Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy	N/A	University of California, San Diego	<1 mi
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH	Phase 3	GlaxoSmithKline	<1 mi
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors	N/A	Johns Hopkins University	<1 mi
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)	Phase 3	Eli Lilly and Company	<1 mi
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition	Phase 2	Regeneron Pharmaceuticals	<1 mi
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH	Phase 3	GlaxoSmithKline	<1 mi
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis	Phase 3	Boehringer Ingelheim	<1 mi
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis	Phase 3	Boehringer Ingelheim	<1 mi
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight	Phase 2	Amgen	<1 mi
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis	Phase 3	Ipsen	2 mi
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics	Phase 1	PharmaIN	2 mi
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH	Phase 3	Akero Therapeutics, Inc	2 mi
A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)	Phase 2	Aligos Therapeutics	2 mi
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH	Phase 3	89bio, Inc.	2 mi
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease	Phase 2	GlaxoSmithKline	2 mi
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis	Phase 2	Mirum Pharmaceuticals, Inc.	2 mi
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)	Phase 3	89bio, Inc.	2 mi
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment	—	Ipsen	2 mi
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)	Phase 3	Bausch Health Americas, Inc.	2 mi
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)	Phase 2	Boehringer Ingelheim	2 mi
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD	Phase 2	Regeneron Pharmaceuticals	2 mi
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3	—	Replimune, Inc.	11 mi
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC	Phase 2	Replimune, Inc.	11 mi
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma	Phase 1/2	Tvardi Therapeutics, Incorporated	11 mi
ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma	Phase 1/2	Abivax S.A.	11 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry	—	Massive Bio, Inc.	11 mi
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies	Phase 1	BioEclipse Therapeutics	11 mi
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours	Phase 1/2	AstraZeneca	11 mi
Time-restricted Eating and Healthy Eating in Patients With Metabolic Liver Disease or Cancer	N/A	University of California, San Diego	11 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy	Phase 3	Pierre Fabre Medicament	11 mi
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma	Phase 1	Alnylam Pharmaceuticals	11 mi
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein	Phase 3	Takeda	11 mi
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)	Phase 2	Altimmune, Inc.	11 mi
Quantitative Ultrasound to Assess Steatotic Liver Disease in Children	—	University of California, San Diego	11 mi
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States	Phase 2	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	11 mi
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)	Phase 3	Takeda	11 mi
Accurate Point of Care Liver Disease Diagnostics (Phase 2)	—	University of California, San Diego	11 mi
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV	Phase 2	Naga P. Chalasani	11 mi
Multi-analyte Blood Test Clinical Trial	—	Helio Genomics	28 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.